alumni, Shailaditya Sengupta was born in Bengal and grew up
in Delhi. He then went to Trinity College as a Nehru Cambridge
and British Chevening Scholar to pursue a PhD in Pharmacology.
Not new to awards, Shiladitya has won the Shakuntala Amir
Chand Prize for excellence in Medical Research from the Indian
Council of Medical Research (ICMR) and the Geeta Mital Gold
Medal from AIIMS. He has also received the Amanda Stavely
Prize in the Cambridge University 50K entrepreneurship competition.
It was at Trinity (he also met his wife Shivani here) that
he started working in the field of angiogenesis. After joining
MIT as a postdoctoral associate, he started working on a problem
that had plagued this field -- how to deliver chemotherapy
after the blood vessels to the tumor have been cut off. As
the Technology Review magazine says, his biggest discovery,
that of the 'nanocell', is a nanoscale drug delivery device
to treat cancer.
Recently, he joined the Harvard Medical School, Brigham and
Women's Hospital as an Assistant Professor of medicine and
the Harvard-MIT Division of Health Sciences and Technology
Shiladitya says, "Getting the TR35 Innovator award was
However, I take pride in the fact that a
significant per cent of the winners were Indians, which reflects
the innovative and entrepreneurial spirit within us as a nation."